clinical trial · NCT07132827
Efficacy and Safety of SHR-1905 Injection in Subjects With Chronic Rhinosinusitis With Nasal Polyps
Guangdong Hengrui Pharmaceutical Co., Ltd·phase3·recruiting·n = 280
Chronic Rhinosinusitis With Nasal PolypsSHR-1905 InjectionSHR-1905 Placebo Injection
brief summary
The study is being conducted to evaluate the efficacy, and safety of SHR-1905 injection in subjects with chronic rhinosinusitis with nasal polyps (CRSwNP)
started
Aug 28, 2025
primary completion
Apr 1, 2028
completion
Apr 1, 2028
last updated
Nov 17, 2025
official title
A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Phase 3 Efficacy and Safety Study of SHR-1905 in Patiens With Chronic Rhinosinusitis With Nasal Polyps
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol